These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Comparison of dual antiplatelet therapy versus oral anticoagulation following transcatheter aortic valve replacement: A retrospective single-center registry analysis. Holy EW; Kebernik J; Allali A; El-Mawardy M; Richardt G; Abdel-Wahab M Cardiol J; 2017; 24(6):649-659. PubMed ID: 28497845 [TBL] [Abstract][Full Text] [Related]
10. Edoxaban Versus Dual Antiplatelet Therapy for Leaflet Thrombosis and Cerebral Thromboembolism After TAVR: The ADAPT-TAVR Randomized Clinical Trial. Park DW; Ahn JM; Kang DY; Kim KW; Koo HJ; Yang DH; Jung SC; Kim B; Wong YTA; Lam CCS; Yin WH; Wei J; Lee YT; Kao HL; Lin MS; Ko TY; Kim WJ; Kang SH; Yun SC; Lee SA; Ko E; Park H; Kim DH; Kang JW; Lee JH; Park SJ; Circulation; 2022 Aug; 146(6):466-479. PubMed ID: 35373583 [TBL] [Abstract][Full Text] [Related]
11. Sex Differences in Outcomes After Transcatheter Aortic Valve Replacement: A POPular TAVI Subanalysis. van Bergeijk KH; van Ginkel DJ; Brouwer J; Nijenhuis VJ; van der Werf HW; van den Heuvel AFM; Voors AA; Wykrzykowska JJ; Ten Berg JM JACC Cardiovasc Interv; 2023 May; 16(9):1095-1102. PubMed ID: 37164609 [TBL] [Abstract][Full Text] [Related]
12. Aspirin Versus Clopidogrel as Single Antithrombotic Therapy After Transcatheter Aortic Valve Replacement: Insight From the OCEAN-TAVI Registry. Kobari Y; Inohara T; Saito T; Yoshijima N; Tanaka M; Tsuruta H; Yashima F; Shimizu H; Fukuda K; Naganuma T; Mizutani K; Yamawaki M; Tada N; Yamanaka F; Shirai S; Tabata M; Ueno H; Takagi K; Watanabe Y; Yamamoto M; Hayashida K Circ Cardiovasc Interv; 2021 May; 14(5):e010097. PubMed ID: 34003663 [TBL] [Abstract][Full Text] [Related]
13. Rationale and design of the ADAPT-TAVR trial: a randomised comparison of edoxaban and dual antiplatelet therapy for prevention of leaflet thrombosis and cerebral embolisation after transcatheter aortic valve replacement. Park H; Kang DY; Ahn JM; Kim KW; Wong AYT; Lam SCC; Yin WH; Wei J; Lee YT; Kao HL; Lin MS; Ko TY; Kim WJ; Kang SH; Ko E; Kim DH; Koo HJ; Yang DH; Kang JW; Jung SC; Lee JH; Yun SC; Park SJ; Park DW BMJ Open; 2021 Jan; 11(1):e042587. PubMed ID: 33402409 [TBL] [Abstract][Full Text] [Related]
14. Apixaban and Valve Thrombosis After Transcatheter Aortic Valve Replacement: The ATLANTIS-4D-CT Randomized Clinical Trial Substudy. Montalescot G; Redheuil A; Vincent F; Desch S; De Benedictis M; Eltchaninoff H; Trenk D; Serfaty JM; Charpentier E; Bouazizi K; Prigent M; Guedeney P; Salloum T; Berti S; Cequier A; Lefèvre T; Leprince P; Silvain J; Van Belle E; Neumann FJ; Portal JJ; Vicaut E; Collet JP; JACC Cardiovasc Interv; 2022 Sep; 15(18):1794-1804. PubMed ID: 36137682 [TBL] [Abstract][Full Text] [Related]
15. Antithrombotic therapy after transcatheter aortic valve replacement: current perspective. Eckstein J; Liu S; Toleva O; Yanagawa B; Verma S; Cheema AN Curr Opin Cardiol; 2021 Mar; 36(2):117-124. PubMed ID: 33394711 [TBL] [Abstract][Full Text] [Related]
16. Antithrombotic therapy in patients undergoing transcatheter aortic valve implantation. Nijenhuis VJ; Brouwer J; Søndergaard L; Collet JP; Grove EL; Ten Berg JM Heart; 2019 May; 105(10):742-748. PubMed ID: 30867148 [TBL] [Abstract][Full Text] [Related]
17. Oral anti-Xa anticoagulation after trans-aortic valve implantation for aortic stenosis: The randomized ATLANTIS trial. Collet JP; Berti S; Cequier A; Van Belle E; Lefevre T; Leprince P; Neumann FJ; Vicaut E; Montalescot G Am Heart J; 2018 Jun; 200():44-50. PubMed ID: 29898848 [TBL] [Abstract][Full Text] [Related]
18. Evolving concepts in the management of antithrombotic therapy in patients undergoing transcatheter aortic valve implantation. van Ginkel DJ; Bor WL; Veenstra L; van 't Hof AWJ; Fabris E Eur J Intern Med; 2022 Jul; 101():14-20. PubMed ID: 35623935 [TBL] [Abstract][Full Text] [Related]